Neuroinflammatory conditions such as diabetes or AD have been shown to cause AMPK inhibition alongside JNK and NF-κB pathway upregulation (Chen et al. 2018a, b; Peixoto et al. 2017). Here, PRKAA2 is linked to Alzheimer disease.